Skip to main content
Clinical Trials/ACTRN12608000178347
ACTRN12608000178347
Not yet recruiting
未知

A prospective study to examine the effectiveness and safety of neuraminidase inhibitors in volunteers who receive long-term prophylaxis against pandemic influenza: PIPET B

ational Centre in HIV Epidemiology and Clinical Research (NCHECR)0 sites1,000 target enrollmentApril 9, 2008

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Centre in HIV Epidemiology and Clinical Research (NCHECR)
Enrollment
1000
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 9, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ational Centre in HIV Epidemiology and Clinical Research (NCHECR)

Eligibility Criteria

Inclusion Criteria

  • 1\. Provision of written informed consent
  • 2\. Intention to commence, or already commenced prophylaxis with a neuraminidase inhibitor in the context of a place of employment or profession
  • It is anticipated that participants in this study who are subsequently clinically diagnosed with pandemic influenza will be enrolled in the Index Case protocol (PIPET\-A) with follow\-up as specified.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials